We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ultragenyx Pharmaceutical
RARE
$2.65B
| $46.6M | 0.06% |
1,133,100
+164,110
| +17% | +$7.01M |
|
277
ASML
ASML
$675B
| $46M | 0.06% |
45,019
+18,658
| +71% | +$17.9M |
|
278
United Microelectronic
UMC
$48.9B
| $46M | 0.06% |
5,248,227
+4,577,177
| +682% | +$37.8M |
|
279
Repligen
RGEN
$7.44B
| $46M | 0.06% |
364,551
+3,864
| +1% | +$606K |
|
280
AstraZeneca
AZN
$263B
| $45.8M | 0.06% |
293,680
-279,139
| -49% | -$42M |
|
281
CME Group
CME
$92.2B
| $45.7M | 0.06% |
+232,200
| New | +$48M |
|
282
Acadia Pharmaceuticals
ACAD
$4.25B
| $45.1M | 0.06% |
2,774,353
+2,251,940
| +431% | +$36.3M |
|
283
Itaú Unibanco
ITUB
$91.3B
| $44.8M | 0.06% |
8,700,659
+5,804,078
| +200% | +$31.8M |
|
284
Hims & Hers Health
HIMS
$6.5B
| $44.5M | 0.06% |
2,205,954
-3,434,276
| -61% | -$57.1M |
|
285
Nice
NICE
$5.29B
| $44.1M | 0.06% |
+256,298
| New | +$52.7M |
|
286
Vital Farms
VITL
$558M
| $43.9M | 0.06% |
937,755
+214,839
| +30% | +$7.41M |
|
287
Star Bulk Carriers
SBLK
$3.14B
| $43.7M | 0.06% |
1,791,426
+903,542
| +102% | +$22.5M |
|
288
MINISO
MNSO
$3.64B
| $43.7M | 0.06% |
2,289,598
-1,508,729
| -40% | -$33.3M |
|
289
Logitech
LOGI
$15.2B
| $43.6M | 0.06% |
450,897
+164,307
| +57% | +$14.8M |
|
290
Iris Energy
IREN
$13.2B
| $43M | 0.06% |
3,811,780
+958,494
| +34% | +$7.18M |
|
291
RH
RH
$3.3B
| $42.6M | 0.06% |
174,324
+64,423
| +59% | +$16.9M |
|
292
Fortune Brands Innovations
FBIN
$6.12B
| $42.3M | 0.06% |
650,745
-450,788
| -41% | -$32.5M |
|
293
Entegris
ENTG
$19.7B
| $42.1M | 0.06% |
+310,833
| New | +$41M |
|
294
SoFi Technologies
SOFI
$21.1B
| $42M | 0.06% |
6,357,887
+3,593,464
| +130% | +$25.3M |
|
295
Stryker
SYK
$127B
| $41.6M | 0.06% |
122,204
-335,370
| -73% | -$114M |
|
296
PUT
Adobe
ADBE
$89.5B
| $41.2M | 0.06% |
74,200
+55,900
| +305% | +$27.1M |
|
297
Western Union
WU
$2.57B
| $40.8M | 0.05% |
3,337,466
+1,142,400
| +52% | +$14.8M |
|
298
PNC Financial Services
PNC
$100B
| $40.3M | 0.05% |
259,049
+254,356
| +5,420% | +$39.4M |
|
299
Murphy Oil
MUR
$5.58B
| $40M | 0.05% |
971,052
-114,749
| -11% | -$5M |
|
300
DexCom
DXCM
$27.6B
| $39.8M | 0.05% |
351,305
+87,305
| +33% | +$11M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.